C. Tschöpe
Cardiology and Cardiovascular Medicine · 2007–2020
A researcher in the Science corpus: 9 papers; trusts 5 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 161 citations into it; #235 of 906 by trust here, #118 by citations
- Radiology, Nuclear Medicine and Imaging — 33 citations into it
- Molecular Biology — 15 citations into it
- Physiology — 6 citations into it
- Immunology — 5 citations into it
Whom C. Tschöpe trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts C. Tschöpe overall
Papers from C. Tschöpe's perspective
Ordered by how strongly the researchers C. Tschöpe trusts endorse each paper. Same corpus, a different order for every researcher.
- Trends in prevalence and outcome of heart failure with preserved ejection fraction. (New England Journal of Medicine)
- Irbesartan in patients with heart failure and preserved ejection fraction. (New England Journal of Medicine)
- Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. (American Journal of Cardiology)
- Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (European Heart Journal-Cardiovascular Imaging)
- Recommendations for chamber quantification. (European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology)
- Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? (Journal of the American College of Cardiology)
- Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction: A Community-Based Study (Journal of the American College of Cardiology)
- Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction (Circulation: Heart Failure)
- Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms (Circulation)
- Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (New England Journal of Medicine)
Their papers
- Myocarditis and inflammatory cardiomyopathy: current evidence and future directions (2020) — 1,017 citations
- Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: an Expert Consensus Document (2020) — 623 citations
- How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). (2019) — 1,457 citations
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) — 597 citations
- Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) — 2,292 citations
- A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. (2013) — 3,322 citations
- Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. (2013) — 743 citations
- Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction: A Comparative Doppler-Conductance Catheterization Study (2007) — 602 citations
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. (2007) — 2,715 citations